Oncology Explore

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Rafael Fonseca MD Editor-in-Chief

Eric Jonasch MD Advisory Board

Lee S. Schwartzberg MD, FACP Advisory Board

See All Experts

Expert Opinion

featured

How Will AI Transform Cancer Care

Interview · October 20, 2024

ESMO
featured

The Global Epidemic of Early-Onset Cancer: Nature, Nurture, or Both?

Interview · October 20, 2024

ESMO
featured

Osimertinib in Unresectable Stage III EGFR Mutated NSCLC: LAURA Study

Interview · October 19, 2024

ESMO
featured

First-in-Human Study of AMG 193, an MTA-Cooperative PRMT5 Inhibitor, in Patients With MTAP-Deleted Solid Tumors: Results From Phase 1 Dose Exploration

Interview · October 19, 2024

ESMO
featured

Niraparib First-Line Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer: Final Overall Survival Results From PRIMA/ENGOT-OV26/GOG-3012 Trial

Interview · October 18, 2024

ESMO

Journal Scans

Distinct Clinical Profiles, Treatment Approaches, and Outcomes in Patients With Atypical CML and CNL

Ann Hematol · November 23, 2024
Olverembatinib for Adult Patients With Newly Diagnosed Philadelphia Chromosome–Positive ALL

Ann Hematol · November 23, 2024
MRI-Based Radiomics for Stratifying Recurrence Risk in Early-Onset Rectal Cancer

ESMO Open · November 23, 2024
Midostaurin Added to 10-Day Decitabine in Patients With AML and Higher-Risk MDS Unfit for Intensive Chemotherapy Irrespective of the FLT3 Mutational Status

Ann Hematol · November 22, 2024
featured

Clinical Outcomes in Patients With T4 and/or N2 Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy

Clin Colorectal Cancer · November 21, 2024

Early Career

Featuring career support, advice, and content geared towards helping medical students and doctors prepare for their first professional role.

featured Early Career

The CV Matters: First Step to Successful Contract Negotiation

Early Career · March 06, 2024
featured Early Career

Nailing Your Personal Statement

Early Career · September 28, 2023
featured Early Career

Imposter Syndrome: Diagnose Accurately Before Treating

Early Career · July 17, 2023
featured Early Career

Acing the Fellowship Interview

Early Career · July 10, 2023
featured Early Career

How Involvement in Research Can Help Develop Your Career

Early Career · July 05, 2023

News

COVID-19 Mortality Higher for Leukemia, Myelodysplastic Syndrome Patients

HealthDay · November 22, 2024
AI Model FastGlioma Can Detect Glioma Infiltration During Surgery

HealthDay · November 22, 2024
Adding Pembrolizumab Ups Survival in Stage III Undifferentiated Sarcoma

HealthDay · November 22, 2024
Fine Particulate Matter Linked to Increased Incidence of Head, Neck Cancer

HealthDay · November 22, 2024
Teledermoscopy Accurate for Detecting Skin Cancers

HealthDay · November 21, 2024

Meet Our Experts

PracticeUpdate is guided by a world-renowned Editorial and Advisory Board that represents community practitioners and academic specialists with cross-disciplinary expertise. View all boards

Cardiology

Douglas Zipes MD
Editor in Chief

Clinical Dentistry

Michael Newman DDS, FACD
Editor in Chief

Dermatology

Robert Brodell MD, FAAD
Editor in Chief

Diabetes

Silvio Inzucchi MD
Editor in Chief

Eye Care

Paul Freeman OD, FAAO, FOVDR
Editor in Chief

Eye Care

Myron Yanoff MD
Editor in Chief

Gastroenterology

Gail Hecht MD
Editor in Chief

Neurology

Mark Hallett MD
Editor in Chief

Oncology

Rafael Fonseca MD
Editor in Chief

Primary Care

David Rakel MD, FAAFP
Editor in Chief

Respiratory Medicine

Shyoko Honiden MD, MSc
Editor in Chief

Welcome to PracticeUpdate,

All Topics

Editor's Picks

Clinical Outcomes in Patients With T4 and/or N2 Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy

Valemetostat Monotherapy for Relapsed or Refractory Non-Hodgkin Lymphoma

Valemetostat for Relapsed or Refractory Peripheral T-Cell Lymphoma

Next-Generation Oral SERD Camizestrant vs Fulvestrant in Postmenopausal ER+/HER2− Advanced Breast Cancer

Efficacy of Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer

Stereotactic Body Radiotherapy for Localized Prostate Cancer

Expert Opinion

How Will AI Transform Cancer Care

The Global Epidemic of Early-Onset Cancer: Nature, Nurture, or Both?

Osimertinib in Unresectable Stage III EGFR Mutated NSCLC: LAURA Study

First-in-Human Study of AMG 193, an MTA-Cooperative PRMT5 Inhibitor, in Patients With MTAP-Deleted Solid Tumors: Results From Phase 1 Dose Exploration

Niraparib First-Line Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer: Final Overall Survival Results From PRIMA/ENGOT-OV26/GOG-3012 Trial

Journal Scans

Distinct Clinical Profiles, Treatment Approaches, and Outcomes in Patients With Atypical CML and CNL

Olverembatinib for Adult Patients With Newly Diagnosed Philadelphia Chromosome–Positive ALL

MRI-Based Radiomics for Stratifying Recurrence Risk in Early-Onset Rectal Cancer

Midostaurin Added to 10-Day Decitabine in Patients With AML and Higher-Risk MDS Unfit for Intensive Chemotherapy Irrespective of the FLT3 Mutational Status

Clinical Outcomes in Patients With T4 and/or N2 Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy

Early Career

The CV Matters: First Step to Successful Contract Negotiation

Nailing Your Personal Statement

Imposter Syndrome: Diagnose Accurately Before Treating

Acing the Fellowship Interview

How Involvement in Research Can Help Develop Your Career

Surveys

News

COVID-19 Mortality Higher for Leukemia, Myelodysplastic Syndrome Patients

AI Model FastGlioma Can Detect Glioma Infiltration During Surgery

Adding Pembrolizumab Ups Survival in Stage III Undifferentiated Sarcoma

Fine Particulate Matter Linked to Increased Incidence of Head, Neck Cancer

Teledermoscopy Accurate for Detecting Skin Cancers

Oops! We have no items to display.

Meet Our Experts

Recently Updated